A small-molecule lycorine derivative protects from obesity by targeting Na + /K + -ATPase α 3 independent of food intake suppression
Authors:
Preprint
Abstract
Obesity remains a severe global public health challenge, with contemporary therapeutic approaches primarily focusing on appetite suppression. Here, we discovered HLY72, a lycorine-derived small molecule that potently counteracts obesity in mice at doses without affecting food intake, by promoting sympathetic activation-mediated lipolysis and thermogenesis in adipose tissues. Mass spectrometry identified Na + /K + -ATPase (NKA) α3, the brain-specific isoform, as HLY72’s target. Only blood-brain barrier-permeable NKA inhibitors reproduce HLY72’s anti-obesity effects, and resistance to HLY72 treatment occurs specifically in NKA α3 (not α1) knockin mice harboring a HLY72-binding mutation. Similar to the chemical inhibition by HLY72, genetic inhibition of NKA α3 also effectively protects mice from diet-induced obesity. These findings point NKA α3 as a potent anti-obesity drug target and highlight HLY72’s potential in treating and preventing obesity independent of appetite control.Keywords
This publication has 35 references indexed in Scilit:
- Local hyperthermia therapy induces browning of white fat and treats obesityCell, 2022
- Obesity therapeutics: The end of the beginningCell Metabolism, 2021
- Neuronal Regulation of Energy Homeostasis: Beyond the Hypothalamus and FeedingCell Metabolism, 2015
- Sympathetic Neuro-adipose Connections Mediate Leptin-Driven LipolysisCell, 2015
- Treatment of Obesity with CelastrolCell, 2015
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Signalling mechanisms regulating lipolysisCellular Signalling, 2006
- Structural basis for E1–E2 conformational transitions in Na, K-pump and Ca-pump proteinsThe Journal of Membrane Biology, 1988
- Studies on digitalis. 23. Blood‐brain barrier of digitoxin in humansClinical Cardiology, 1979